Founded in 1991 and based in Doylestown, Pennsylvania, the Hepatitis B Foundation is a biotechnology company that focuses on funding research, promoting disease awareness, supporting immunization and treatment initiatives, and serving as a primary source of information for patients, medical professionals, and the general public affected by hepatitis B.